153 related articles for article (PubMed ID: 6164030)
1. Vasodilation and the etiology of diabetic retinopathy: a new model.
Wolbarsht ML; Landers MB; Stefansson E
Ophthalmic Surg; 1981 Feb; 12(2):104-7. PubMed ID: 6164030
[TBL] [Abstract][Full Text] [Related]
2. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
Wolbarsht ML; Landers MB
Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
[TBL] [Abstract][Full Text] [Related]
3. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies.
Stefansson E; Landers MB; Wolbarsht ML
Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118
[TBL] [Abstract][Full Text] [Related]
4. [Microcirculation disturbances at the onset of diabetic retinopathy. New therapeutic procedures? (author's transl)].
Jütte A; Deufrains A; Dietze U
Klin Monbl Augenheilkd; 1980 Jul; 177(1):1-6. PubMed ID: 7005511
[TBL] [Abstract][Full Text] [Related]
5. [What is the etiology of diabetic retinopathy?].
Wiedemann P
Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625
[TBL] [Abstract][Full Text] [Related]
6. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes.
Nguyen TT; Kawasaki R; Kreis AJ; Wang JJ; Shaw J; Vilser W; Wong TY
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5609-13. PubMed ID: 19643973
[TBL] [Abstract][Full Text] [Related]
7. [The role of the osmotic pressure of the blood in the pathogenesis of diabetic changes in the retina].
Zapuskalov IV; Filippova SV; Shilova OG; Krivosheina OI
Vestn Oftalmol; 2000; 116(2):32-4. PubMed ID: 11055223
[TBL] [Abstract][Full Text] [Related]
8. Influence of flickering light on the retinal vessels in diabetic patients.
Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA
Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481
[TBL] [Abstract][Full Text] [Related]
9. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
10. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
11. Retinopathy of prematurity: a new look at an old disease.
Wolbarsht ML; George GS; Shearin WA; Kylstra JA; Landers MB
Ophthalmic Surg; 1983 Nov; 14(11):919-24. PubMed ID: 6197686
[TBL] [Abstract][Full Text] [Related]
12. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of vascular permeability in diabetic retinopathy.
Antonetti DA; Lieth E; Barber AJ; Gardner TW
Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approach to diabetic retinopathy.
De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
[TBL] [Abstract][Full Text] [Related]
15. Introductory comments for session V "neovasculogenesis" presented at the fifth symposium, the International Society on Metabolic Eye Disease October 24-26, 1982.
Waitzman MB
Metab Pediatr Syst Ophthalmol; 1983; 7(2):71-4. PubMed ID: 6197603
[TBL] [Abstract][Full Text] [Related]
16. Retinal vessel oxygen saturation under flicker light stimulation in patients with nonproliferative diabetic retinopathy.
Hammer M; Heller T; Jentsch S; Dawczynski J; Schweitzer D; Peters S; Schmidtke KU; Müller UA
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4063-8. PubMed ID: 22589440
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
Favard C; Ortega N; Bayard F; Plouet J
Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of diabetic retinopathy].
Dhermy P; Toussaint D
Bull Soc Belge Ophtalmol; 1980; (188-189):73-85. PubMed ID: 7248656
[No Abstract] [Full Text] [Related]
20. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
Gacka M; Adamiec J
Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
